HomeTherapeutic areasImmunology › Crohn's Disease

Crohn's Disease (3 companies)

Companies with an active program in Crohn's Disease.

Ticker Company Therapeutic areas Programs Lead stage Programs
AGMB Agomab Therapeutics ImmunologyRespiratory Rare 1 Phase 2 4
SYRE Spyre Therapeutics Immunology 3 Phase 2 12
XNCR Xencor HematologyImmunology+4 Rare 2 Approved 30